Enovis Corp., a healthcare company based in the United States, specializes in developing innovative medical technology solutions to improve patient outcomes. With a focus on ESG principles, Enovis Corp. manufactures high-quality medical devices for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through two segments: Prevention & Recovery (P&R) and Reconstructive (Recon), with a high-risk rating score of 31.8. Enovis Corp. primarily generates revenue from its Prevention & Recovery segment.